Sarah L. Buchan

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, Joe Grove, Oscar A. MacLean et al. · Nature Microbiology · 2022 · 724 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Sarah L. Buchan, Lang Dou, Marcus Remer et al. · Immunity · 2018 · 153 citations · Full text

Life Sciences, Immunology, Oncology +14

Genomic reconstruction of the SARS-CoV-2 epidemic in England

Harald Vöhringer, Theo Sanderson, Matthew Sinnott et al. · Nature · 2021 · 119 citations · Full text

Veterinary Medicine, Genetics, Infectious Diseases +14

PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough et al. · Clinical Cancer Research · 2018 · 112 citations · Full text

Life Sciences, Immunology, Oncology +17

Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor Antigen

Sarah L. Buchan, Eirik Grønevik, Iacob Mathiesen et al. · The Journal of Immunology · 2005 · 102 citations

Medicine, Immunology, Oncology +17